RenovoRx, Inc. (RNXT) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts RNXT Hot Sheet
Join SI Premium – FREE
RenovoRx, Inc. (NASDAQ: RNXT) reported Q3 EPS of ($0.08), in-line with the analyst estimate of ($0.08). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $397.07 thousand.
For earnings history and earnings-related data on RenovoRx, Inc. (RNXT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pullback in chip stocks is a buying opportunity, Citi says
- ArcelorMittal Q2 2026 analyst consensus: $2.04B EBITDA expected
- Oregon Pacific Bancorp (ORPB) Tops Q2 EPS by 38c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
